Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis

Acta Tropica

Volumn 115, Issue 1-2, 2010, Pages 155-162

  Medeiros, Fernanda da Rocha ^a   Spichler, Anne ^b   Athanazio, Daniel A ^c  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b Hospital Emilio Ribas   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Disease; Hemorrhage; Leptospirosis; Pulmonary; Vasculitis

Indexed keywords

COMPLEMENT COMPONENT C3; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; HYDROCARBON; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VON WILLEBRAND FACTOR;

BACTERIAL DISEASE; BLOOD; BLOOD SYSTEM DISORDER; IMMUNITY;

ADULT RESPIRATORY DISTRESS SYNDROME; AUTOIMMUNITY; BLOOD CLOTTING DISORDER; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM INJURY; HUMAN; KIDNEY DYSFUNCTION; LEPTOSPIROSIS; LUNG HEMORRHAGE; NONHUMAN; PATHOGENESIS; PROGNOSIS; REVIEW; SEPSIS; STRAIN DIFFERENCE; SYSTEMIC VASCULITIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANIMALS; BLOOD VESSELS; HEMOSTATIC DISORDERS; HUMANS; LEPTOSPIROSIS; LUNG; SEPSIS;

ANIMALIA;

EID: 77953022088     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2010.02.016     Document Type: Review

References (81)

1. Ankri A., Bonmarchand M., Coutellier A., Herson S., Karmochkine M. Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients. AIDS 1999, 13:1282-1283.
2. Arean V.M. The pathologic anatomy and pathogenesis of fatal human leptospirosis (Weil's disease). Am. J. Pathol. 1962, 40:393-423.
3. Arean V.M. Studies on the pathogenesis of leptospirosis. II. A clinicopathologic evaluation of hepatic and renal function in experimental leptospiral infections. Lab. Invest. 1962, 11:273-288.
4. Athanazio D.A., Silva E.F., Santos C.S., Rocha G.M., Vannier-Santos M.A., McBride A.J.A., Ko A.I., Reis M.G. Rattus norvegicus as a model for persistent renal colonization by pathogenic Leptospira interrogans. Acta Trop. 2008, 105:176-180.
5. Bharti A.R., Nally J.E., Ricaldi J.N., Matthias M.A., Diaz M.M., Lovett M.A., Levett P.N., Gilman R.H., Willig M.R., Gotuzzo E., Vinetz J.M. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 2003, 3:757-771.
6. Chen H.I., Kao S.J., Hsu Y.H. Pathophysiological mechanism of lung injury in patients with leptospirosis. Pathology 2007, 39:339-344.
7. Chen Y. A clinicopathological analysis of 12 cases of cerebrovascular leptospirosis. Chung Hua Shen Ching Ching Shen Ko Tsa Chih 1990, 23:226-228.
8. Chierakul W., Tientadakul P., Suputtamongkol Y., Wuthiekanun V., Phimda K., Limpaiboon R., Opartkiattikul N., White N.J., Peacock S.J., Day N.P. Activation of the coagulation cascade in patients with leptospirosis. Clin. Infect. Dis. 2008, 46:254-460.
9. Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., Patel K.D., Chakrabarti S., McAvoy E., Sinclair G.D., Keys E.M., Allen-Vercoe E., Devinney R., Doig C.J., Green F.H., Kubes P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 2007, 13:463-469.
10. Costa E., Costa Y.A., Lopes A.A., Sacramento E., Bina J.C. Severe forms of leptospirosis: clinical, demographic and environmental aspects. Rev. Soc. Bras. Med. Trop. 2001, 34:261-267.
11. Craig S.B., Graham G.C., Burns M.A., Dohnt M.F., Wilson R.J., Smythe L.D., Jansen C.C., McKay D.B. Leptospirosis and Goodpasture's syndrome: testing the aetiological hypothesis. Ann. Trop. Med. Parasitol. 2009, 103:647-651.
12. Croda J., Neto A.N., Brasil R.A., Pagliari C., Nicodemo A.C., Duarte M.I. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin. Microbiol. Infect. 2009, (published online: September 23, 2009, 10:28 AM). 10.1111/j.1469-0691.2009.02916.x.
13. Cui Z., Wang H.Y., Zhao M.H. Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006, 69:894-899.
14. da Silva J.J., Netto B.A., Lilembaum W., Alvim M.E., de Oliveira A.V. The hemorrhagic syndrome of leptospirosis: an experimental study in guinea pigs. Rev. Soc. Bras. Med. Trop. 1995, 28:169-177.
15. Davenport A., Rugman F.P., Desmond M.J., Ganta R. Is thrombocytopenia seen in patients with leptospirosis immunologically mediated?. J. Clin. Pathol. 1989, 42:439-440.
16. De Brito T., Bohm G.M., Yasuda P.H. Vascular damage in acute experimental leptospirosis of the guinea-pig. J. Pathol. 1979, 128:177-182.
17. de Brito T., Morais C.F., Yasuda P.H., Lancellotti C.P., Hoshino-Shimizu S., Yamashiro E., Ferreira Alves V.A. Cardiovascular involvement in human and experimental leptospirosis: pathologic findings and immunohistochemical detection of leptospiral antigen. Ann. Trop. Med. Parasitol. 1987, 81:207-214.
18. de Carvalho J.E., Marchiori E.d.S., Guedes e Silva J.B., Netto B.A., Tavares W., de Paula A.V. Pulmonary compromise in leptospirosis. Rev. Soc. Bras. Med. Trop. 1992, 25:21-30.
19. De Francesco Daher E., Oliveira Neto F.H., Ramirez S.M. Evaluation of hemostasis disorders and anticardiolipin antibody in patients with severe leptospirosis. Rev. Inst. Med. Trop. Sao Paulo 2002, 44:85-90.
20. Edwards C.N., Nicholson G.D., Everard C.O. Thrombocytopenia in leptospirosis. Am. J. Trop. Med. Hyg. 1982, 31:827-829.
21. Endler G., Marsik C., Jilma B., Schickbauer T., Vormittag R., Wagner O., Mannhalter C., Rumpold H., Pabinger I. Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. Clin. Chem. 2006, 52:1040-1044.
22. Faine S.B., Adler B., Bolin C., Perolat P. Leptospira and Leptospirosis 1999, MediSci, Melbourne, Australia. 2nd ed.
23. Gong Y.H. Leptospiral cerebral arteritis: report of 4 autopsy cases. Acta Acad. Med. Wuhan 1984, 4:44-49.
24. Gouveia E.L., Metcalfe J., de Carvalho A.L.F., Aires T.S.F., Villalobos-Bisneto J.C., Queiroz A., Santos A.C., Salgado K., Reis M.G., Ko A.I. Leptospirosis-associated severe pulmonary hemorrhage syndrome, Salvador, Brazil. Emerg. Infect. Dis. 2008, 14:505-508.
25. Green R.J., Ruoss S.J., Kraft S.A., Duncan S.R., Berry G.J., Raffin T.A. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 1996, 110:1305-1316.
26. Hassan A.A., Kroll M.H. Acquired disorders of platelet function. Hematol. Am. Soc. Hematol. Educ. Program 2005, 403-408.
27. Homs C., Olave T., Benito R., Iturbe T. Plasma exchange support therapy in icterohemorrhagic leptospirosis. Enferm. Infecc. Microbiol. Clin. 2003, 21:166-167.
28. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
29. Jennette J.C., Nickeleit V. Anti-glomerular basement membrane glomerulonephritis and Goodpasture's syndrome. Heptinstall's Pathology of the Kidney 2007, vol. 1:613-641. Lippincott Williams & Wilkins, Philadelphia. 6th ed.
30. Laing R.W., Teh C., Toh C.H. Thrombotic thrombocytopenic purpura (TTP) complicating leptospirosis: a previously undescribed association. J. Clin. Pathol. 1990, 43:961-962. (letter).
31. Ma A.C., Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J. Thromb. Haemost. 2008, 6:415-420.
32. Macedo V., Figueiredo J.F.M., Carvalho E., Barbosa E. Disseminated intravascular coagulation in leptospirosis. Rev. Pathol. Trop. 1973, 2:363-366.
33. Maciel E.A., Athanazio D.A., Reis E.A., Cunha F.Q., Queiroz A., Almeida D., McBride A.J., Ko A.I., Reis M.G. High serum nitric oxide levels in patients with severe leptospirosis. Acta Trop. 2006, 100:256-260.
34. Marinho M., Oliveira-Júnior I.S., Monteiro C.M.R., Perri S.H., Salomão R. Pulmonary disease in hamsters infected with Leptospira interrogans: histopathologic findings and cytokine mRNA expressions. Am. J. Trop. Med. Hyg. 2009, 80:832-836.
35. Marotto P.C., Nascimento C.M., Eluf-Neto J., Marotto M.S., Andrade L., Sztajnbok J., Seguro A.C. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin. Infect. Dis. 1999, 29:1561-1563.
36. Martinez Garcia M.A., de Diego Damia A., Menendez Villanueva R., Lopez Hontagas J.L. Pulmonary involvement in leptospirosis. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:471-474.
37. McBride A.J., Athanazio D.A., Reis M.G., Ko A.I. Leptospirosis. Curr. Opin. Infect. Dis. 2005, 18:376-386.
38. Nally J.E., Chantranuwat C., Wu X.Y., Fishbein M.C., Pereira M.M., Da Silva J.J., Blanco D.R., Lovett M.A. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am. J. Pathol. 2004, 164:1115-1127.
39. Nally J.E., Fishbein M.C., Blanco D.R., Lovett M.A. Lethal infection of C3H/HeJ and C3H/SCID mice with an isolate of Leptospira interrogans serovar copenhageni. Infect. Immun. 2005, 73:7014-7017.
40. Nascimento A.L., Ko A.I., Martins E.A., Monteiro-Vitorello C.B., Ho P.L., Haake D.A., Verjovski-Almeida S., Hartskeerl R.A., Marques M.V., Oliveira M.C., Menck C.F., Leite L.C., Carrer H., Coutinho L.L., Degrave W.M., Dellagostin O.A., El-Dorry H., Ferro E.S., Ferro M.I., Furlan L.R., Gamberini M., Giglioti E.A., Goes-Neto A., Goldman G.H., Goldman M.H., Harakava R., Jeronimo S.M., Junqueira-de-Azevedo I.L., Kimura E.T., Kuramae E.E., Lemos E.G., Lemos M.V., Marino C.L., Nunes L.R., de Oliveira R.C., Pereira G.G., Reis M.S., Schriefer A., Siqueira W.J., Sommer P., Tsai S.M., Simpson A.J., Ferro J.A., Camargo L.E., Kitajima J.P., Setubal J.C., Van Sluys M.A. Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis. J. Bacteriol. 2004, 186:2164-2172.
41. Natarajaseenivasan K., Vijayachari P., Sharma S., Roy S., Sugunan A.P., Biswas D., Sehgal S.C. Phylogenetic relatedness among leptospiral strains belonging to same serovar recovered from patients with different clinical syndromes. Infect. Genet. Evol. 2005, 5:185-191.
42. Navarro C.E., Kociba G.J. Hemostatic changes in dogs with experimental Leptospira interrogans serovar icterohaemorrhagiae infection. Am. J. Vet. Res. 1982, 43:904-906.
43. Nicodemo A.C., Del Negro G., Amato Neto V. Thrombocytopenia and leptospirosis. Rev. Inst. Med. Trop. Sao Paulo 1990, 32:252-259.
44. Nicodemo A.C., Duarte M.I., Alves V.A., Takakura C.F., Santos R.T., Nicodemo E.L. Lung lesions in human leptospirosis: microscopic, immunohistochemical, and ultrastructural features related to thrombocytopenia. Am. J. Trop. Med. Hyg. 1997, 56:181-187.
45. Niwattayakul K., Homvijitkul J., Niwattayakul S., Khow O., Sitprija V. Hypotension, renal failure, and pulmonary complications in leptospirosis. Ren. Fail. 2002, 24:297-305.
46. Paganin F., Bourdin A., Dalban C., Courtin J.P., Poubeau P., Borgherini G., Michault A., Sally J.C., Tixier F., Genin R., Arvin-Berod C. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med. 2007, 33:1959-1966.
47. Park S.K., Lee S.H., Rhee Y.K., Kang S.K., Kim K.J., Kim M.C., Kim K.W., Chang W.H. Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am. J. Trop. Med. Hyg. 1989, 41:345-351.
48. Pereira da Silva J.J., Paiva L.M., Silva J.B.G., Alves Netto B. Study on pulmonary compromise in Weil's disease. Rev. Inst. Med. Trop. Sao Paulo 1976, 18:387-392.
49. Pereira M.M., Andrade J., Marchevsky R.S., Ribeiro dos Santos R. Morphological characterization of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression. Exp. Toxicol. Pathol. 1998, 50:191-198.
50. Pereira M.M., Da Silva J.J., Pinto M.A., Da Silva M.F., Machado M.P., Lenzi H.L., Marchevsky R.S. Experimental leptospirosis in marmoset monkeys (Callithrix jacchus): a new model for studies of severe pulmonary leptospirosis. Am. J. Trop. Med. Hyg. 2005, 72:13-20.
51. Pereira M.M., Matsuo M.G.S., Bauab A.R., Vasconcelos S.A., Moraes Z.M., Baranton G., Saint G.I. A clonal subpopulation of Leptospira interrogans sensu stricto is the major cause of leptospirosis outbreaks in Brazil. J. Clin. Microbiol. 2000, 38:450-452.
52. Ren S.X., Fu G., Jiang X.G., Zeng R., Miao Y.G., Xu H., Zhang Y.X., Xiong H., Lu G., Lu L.F., Jiang H.Q., Jia J., Tu Y.F., Jiang J.X., Gu W.Y., Zhang Y.Q., Cai Z., Sheng H.H., Yin H.F., Zhang Y., Zhu G.F., Wan M., Huang H.L., Qian Z., Wang S.Y., Ma W., Yao Z.J., Shen Y., Qiang B.Q., Xia Q.C., Guo X.K., Danchin A., Saint G.I., Somerville R.L., Wen Y.M., Shi M.H., Chen Z., Xu J.G., Zhao G.P. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 2003, 422:888-893.
53. Salkade H.P., Divate S., Deshpande J.R., Kawishwar V., Chaturvedi R., Kandalkar B.M., Vaideeswar P. A study of autopsy findings in 62 cases of leptospirosis in a metropolitan city in India. J. Postgrad. Med. 2005, 51:169-173.
54. Santiago M., Martinelli R., Reis M.G., Reis E.A., Ko A., Fontes R.D., Silva M.P., Nascimento E.G., de Jesus R., Pierangeli S., Espinola R., Gharavi A. Diagnostic performance of anti-beta2 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome. Clin. Rheumatol. 2004, 23:485-489.
55. Schlesinger N., Schlesinger M., Seshan S.V. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J. Rheumatol. 2005, 32:1053-1057.
56. Segura E.R., Ganoza C.A., Campos K., Ricaldi J.N., Torres S., Silva H., Cespedes M.J., Matthias M.A., Swancutt M.A., Lopez Linan R., Gotuzzo E., Guerra H., Gilman R.H., Vinetz J.M. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin. Infect. Dis. 2005, 40:343-351.
57. Silva E.F., Santos C.S., Athanazio D.A., Seyffert N., Seixas F.K., Cerqueira G.M., Fagundes M.Q., Brod C.S., Reis M.G., Dellagostin O.A., Ko A.I. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 2008, 26:3892-3896.
58. Silva J.J., Dalston M.O., Carvalho J.E., Setubal S., Oliveira J.M., Pereira M.M. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev. Soc. Bras. Med. Trop. 2002, 35:395-399.
59. Siriwanij T., Suttinont C., Tantawichien T., Chusil S., Kanjanabuch T., Sitprija V. Haemodynamics in leptospirosis: effects of plasmapheresis and continuous venovenous haemofiltration. Nephrology (Carlton) 2005, 10:1-6.
60. Spichler A., Athanazio D., Buzzar M., Castro B., Chapolla E., Seguro A., Vinetz J. Using death certificate reports to find severe leptospirosis cases, Brazil. Emerg. Infect. Dis. 2007, 13:1559-1561.
61. Spichler A., Athanazio D., Vilaça P., Buzzar M., Castro B., Chapolla E., Seguro A. Interrelationship between thrombocytopenia, acute renal failure and pulmonary involvement in severe leptospirosis. 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene 2008, S132.
62. Spichler A., Athanazio D., Vilaça P., Chapolla E., Buzzar M., Castro B., Seguro A. Similarities and differences between pediatric and adult leptospirosis in Sao Paulo, Brazil. 57th Annual Meeting of the American Society of Tropical Medicine and Hygiene 2008, S126.
63. Spichler A.S., Vilaça P.J., Athanazio D.A., Albuquerque J.O.M., Buzzar M., Castro B., Seguro A., Vinetz J. Predictors of lethality in severe leptospirosis in Urban Brazil. Am. J. Trop. Med. Hyg. 2008, 79:911-914.
64. Stojanovich L. Pulmonary manifestations in antiphospholipid syndrome. Autoimmun. Rev. 2006, 5:344-348.
65. Tajiki H., Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin. Infect. Dis. 1996, 23:1177-1178.
66. Thammakumpee K., Silpapojakul K., Borrirak B. Leptospirosis and its pulmonary complications. Respirology 2005, 10:656-659.
67. Thiermann A.B. Effect of cyclophosphamide treatment on clinical and serologic response of rats to infection with Leptospira interrogans serovar icterohaemorrhagiae. Am. J. Vet. Res. 1980, 41:1655-1658.
68. Trevejo R.T., Rigau-Perez J.G., Ashford D.A., McClure E.M., Jarquin-Gonzalez C., Amador J.J., De Los Reyes J.O., Gonzalez A., Zaki S.R., Shieh W.-J., McLean R.G., Nasci R.S., Weyant R.S., Bolin C.A., Bragg S.L., Perkins B.A., Spiegel R.A. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J. Infect. Dis. 1998, 178:1457-1463.
69. Turhan V., Senol M.G., Sonmez G., Oncul O., Cavuslu S., Tanridag O. Cerebral venous thrombosis as a complication of leptospirosis. J. Infect. 2006, 53:e247-e249.
70. van der Werf N., Kroese F.G., Rozing J., Hillebrands J.L. Viral infections as potential triggers of type 1 diabetes. Diabetes Metab. Res. Rev. 2007, 23:169-183.
71. van Gorp E.C., Suharti C., ten Cate H., Dolmans W.M., van der Meer J.W., ten Cate J.W., Brandjes D.P. Review: infectious diseases and coagulation disorders. J. Infect. Dis. 1999, 180:176-186.
72. Vinetz J.M. Leptospirosis. Curr. Opin. Infect. Dis. 2001, 14:527-538.
73. Viriyakosol S., Matthias M.A., Swancutt M.A., Kirkland T.N., Vinetz J.M. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect. Immun. 2006, 74:887-895.
74. Wagenaar J.F., Goris M.G., Gasem M.H., Isbandrio B., Moalli F., Mantovani A., Boer K.R., Hartskeerl R.A., Garlanda C., van Gorp E.C. Long pentraxin PTX3 is associated with mortality and disease severity in severe leptospirosis. J. Infect. 2009, 58:425-432.
75. Wagenaar J.F., Goris M.G., Partiningrum D.L., Isbandrio B., Hartskeerl R.A., Brandjes D.P., Meijers J.C., Gasem M.H., van Gorp E.C. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality. Trop. Med. Int. Health 2010, 15:152-159.
76. Wakamatsu A., Pagano L.S., Gayotto L.C., Santos R.T., Sakata E.E., Kanamura C.T., Candelori I., Pestana C.B., Yasuda P.H., Alves V.A. High resolution light microscopy: adaptation of the method and its use in the study of experimental leptospirosis in guinea pigs. Rev. Hosp. Clin. Fac. Med. Sao Paulo 1990, 45:47-52.
77. Yang G.G., Hsu Y.H. Nitric oxide production and immunoglobulin deposition in leptospiral hemorrhagic respiratory failure. J. Formos. Med. Assoc. 2005, 104:759-763.
78. Yang H.L., Jiang X.C., Zhang X.Y., Li W.J., Hu B.Y., Zhao G.P., Guo X.K. Thrombocytopenia in the experimental leptospirosis of guinea pig is not related to disseminated intravascular coagulation. BMC Infect. Dis. 2006, 6:19.
79. Yang J., Zhang Y., Xu J., Geng Y., Chen X., Yang H., Wang S., Wang H., Jiang X., Guo X., Zhao G. Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. PLoS ONE 2009, 4:e4181.
80. Yang R., Cui Z., Hellmark T., Segelmark M., Zhao M.H., Wang H.Y. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. Clin. Immunol. 2007, 124:207-212.
81. Zamora M.R., Warner M.L., Tuder R., Schwarz M.I. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997, 76:192-202.